Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
3
institutions
Market cap
$214.3B
372M shares
52-week range
$435.27 – $643.99
68% from low
Sector
MEASURING & CONTROLLING DEVICES, NEC
Exchange
NYSE
CS
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
www.thermofisher.comNo one on the platform currently holds TMO.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 138,964 | $68.3M |
| Third Point LLCas of 2025-12-31 | 50,000 | $29.0M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-09-15 | $0.4700 | 2026-10-15 |
| 2026-06-15 | $0.4700 | 2026-07-15 |
| 2026-03-13 | $0.4700 | 2026-04-15 |
| 2025-12-15 | $0.4300 | 2026-01-15 |
| 2025-09-15 | $0.4300 | 2025-10-15 |
| 2025-06-13 | $0.4300 | 2025-07-15 |
| 2025-03-14 | $0.4300 | 2025-04-15 |
| 2024-12-13 | $0.3900 | 2025-01-15 |
| 2024-09-13 | $0.3900 | 2024-10-15 |
| 2024-06-14 | $0.3900 | 2024-07-15 |
No one on the platform has traded TMO yet.
| 14,487 |
| $7.1M |
| 2024-03-14 | $0.3900 | 2024-04-15 |
| 2023-12-14 | $0.3500 | 2024-01-16 |
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
The most recent New High signal on $TMO triggered on 2026-07-28. The expected return for the selected horizon is +9.32% with a historical profit probability of +77.98%. Learn more: https://axlfi.com/factor-analysis?symbol=TMO&factor=new_high&timeframe=daily
View on StockTwits ↗$TMO Big moves expected once this 5yr base breaks. Nice action after the latest earning beats.
View on StockTwits ↗$TMO Buy Deutsche Bank raises target price to $635 from $630 Evercore ISI raises PT to $615 from $570 JP Morgan raises target price to $690 from $600 Leerink Partners raises PT to $620 from $600 RBC raises target price to $580 from $490 TD Cowen raises target price to $675 from $625
View on StockTwits ↗$TMO Positive (92%): shares should receive upward support because the earnings beat and higher 2026 outlook raise expected future profit and reduce the risk that analysts will cut near-term estimates. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/522b28ef574857a4?utm_source=stocktwits&utm_medium=story_url
View on StockTwits ↗$CNSP $CDT $EDBL $DHR $TMO Bull Flag Price action. CNS-Pharmaceuticals CNSP is rebounding. Now get on the CNS Pharmaceuticals CNSP moon rocket 9700% on Monday open. FAST TRACK DESIGNATION + ORPHAN DRUG DESIGNATION + INTELLECTUAL PROPERTY COMMERCIALIZATION RIGHTS in E.U. & U.S.
View on StockTwits ↗$TMO this can touch 600 again. Let’s see if upgrades come in next week.
View on StockTwits ↗@judgeyoung2 @Jeremymartin007 @jenbunn @ZY786 @EBE_day @ribbey @TraderRapp @Tradermikes40 @tonyctl @zuby34 $PGR $TMUS $TMO $LMT $RTX Judge, u miss out on best ones and after seeing those misses, u chase less bueno ones?? Gotta wait till see multilegs!
View on StockTwits ↗$TMO this is starting to look like a trend, not just a bounce
View on StockTwits ↗$TMO the figures also says plenty about the boyancy of small and mid biotech market.... and the sector activity
View on StockTwits ↗$TMO crushing earnings! Shares gap up over +9% intraday into the $574-$579 resistance zone! Thermo Fisher Scientific ($TMO) surged after earnings, with heavy buying volume breaking above the downtrend line, signaling strong institutional accumulation. The setup shows clear right-side momentum expansion. While the gap-up leaves room for possible retests, holding the new key support area could keep the bullish structure intact. Watch what price is telling you.
View on StockTwits ↗$TMO AITX now has one global logistics customer operating dozens of RAD devices across its network. That's meaningful enterprise adoption.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $47.8B | +8.0% | $25.08 | $24.75–$25.34 | 23.0× | 14 |
| 2027 | $50.3B | +5.2% | $27.40 | $26.22–$29.03 | 21.0× | 16 |
| 2028 | $53.5B | +6.3% | $30.21 | $27.12–$32.91 | 19.1× | 5 |
| 2029 | $56.7B | +6.1% | $34.04 | $33.50–$34.55 | 16.9× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-23 | $5.72 | $6.03 | +5.4% |
| 2026-04-23 | $5.25 | $5.44 | +3.6% |
| 2026-01-29 | $6.45 | $6.57 | +1.9% |
| 2025-10-22 | $5.50 | $5.79 | +5.3% |
| 2025-07-23 | $5.23 | $5.36 | +2.5% |
| 2025-04-23 | $5.10 | $5.15 | +1.0% |
| 2025-01-30 | $5.94 | $6.10 | +2.7% |
| 2024-10-23 | $5.25 |
| $5.28 |
| +0.6% |
| $132.8B |
| — |
| DHRDanaher Corporation | $196.29 | -0.10% | $138.0B | — |
| IQVIQVIA Holdings Inc. | $237.82 | -3.93% | $39.1B | — |
Source: Financial Modeling Prep · peers by sector/industry